V6‐peptides can efficiently block HGF‐induced hepatocyte growth factor receptor (or Met) activation and downstream signaling.20 Furthermore, v6‐peptide treatment of HT29 colon carcinoma cells has been shown to strongly inhibit their HGF/Met‐stimulated cell detachment and scattering. This evidence concerns the gene MET and colon carcinoma.